FREE NEWSLETTER

The Campari Playbook: What Disciplined Brand Building Actually Looks Like in a Downturn

In full year 2025, one major spirits company delivered organic net sales growth, margin expansion, leverage reduction ahead of plan, and a 54% dividend increase simultaneously. Every other major producer in the same period reported organic decline, margin pressure, or both. The company was Campari Group.

The result was not luck and it was not category positioning. Aperol and the aperitivo category are genuinely well-placed, but the aperitivo category did not protect everyone in it equally. The Campari result was the consequence of specific decisions made across brand investment, financial management, and portfolio architecture over the previous three to five years – decisions that are now visible in the 2025 numbers for anyone willing to read them carefully.

This piece makes four specific arguments about what Campari did differently. They are not generic strategic principles. They are documented decisions, evidenced in the financial statements, that produced a specific and measurable outcome in one of the most difficult operating environments the global spirits industry has faced in a generation.

Organic Net Sales Growth – Campari vs Major Peers
The gap that matters
Organic net sales growth, most recent full reported period. Campari FY2025 vs Diageo H1 FY26, Pernod Ricard nine months FY26, and Brown-Forman nine months FY26. Periods are not identical – shown for directional comparison only.
Periods differ across companies – Campari FY2025 (full year), Diageo H1 FY26 (six months), Pernod Ricard 9M FY26 (nine months), Brown-Forman 9M FY26 (nine months). Directional comparison only.
Campari Group FY2025 Investor Presentation, 4 Mar 2026 – Diageo H1 FY26 Interim Results, 25 Feb 2026 – Pernod Ricard Q3 FY26 press release, 16 Apr 2026 – Brown-Forman Q3 FY26 Results, 4 Mar 2026

Argument one: they invested in brands when the pressure was to cut

Free newsletter
Daily drinks industry intelligence. No subscription needed.
Continue reading
Start your 30-day trial for £1 / $1 / €1. Cancel anytime.
  • -Daily coverage
  • -Market and category analysis
  • -Financial results coverage
  • -Practical industry guides
  • -Interviews
  • -Monthly intelligence briefing
Start 30-day trial - £1 / $1 / €1
Already a member? Sign in here.